B7-H4.Ig inhibits the development of Type 1 diabetes by regulating Th17 cells in NOD mice

Cellular Immunology

Volumn 282, Issue 1, 2013, Pages 1-8

  Lee, I Fang ^a   Wang, Xiaojie ^a   Hao, Jianqiang ^a   Akhoundsadegh, Noushin ^a   Chen, Lieping ^b   Liu, Linda ^c   Langermann, Sol ^c   Ou, Dawei ^a   Warnock, Garth L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Amplimmune Inc   (United States)

Author keywords

B7 H4; Cell differentiation; Interferon gamma; T helper 17 Cells; Type 1 diabetes

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 17; RECOMBINANT PROTEIN;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CELL COUNT; CELL DIFFERENTIATION; COCULTURE; CONTROLLED STUDY; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH17 CELL;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DIABETES MELLITUS, TYPE 1; FEMALE; FLOW CYTOMETRY; IMMUNOGLOBULINS; INSULIN-SECRETING CELLS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICE; MICE, INBRED NOD; RECOMBINANT FUSION PROTEINS; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TH17 CELLS; V-SET DOMAIN-CONTAINING T-CELL ACTIVATION INHIBITOR 1;

ANIMALIA; MUS;

EID: 84876741481     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.03.005     Document Type: Article

References (46)

1. Tisch R., McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996, 85:291-297.
2. Muir A., Peck A., Clare-Salzler M., Song Y.H., Cornelius J., Luchetta R., Krischer J., Maclaren N. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J. Clin. Invest. 1995, 95:628-634.
3. Wen L., Wong F.S., Tang J., Chen N.Y., Altieri M., David C., Flavell R., Sherwin R. In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes. J. Exp. Med. 2000, 191:97-104.
4. Sica G.L., Choi I.H., Zhu G., Tamada K., Wang S.D., Tamura H., Chapoval A.I., Flies D.B., Bajorath J., Chen L. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 2003, 18:849-861.
5. Prasad D.V., Richards S., Mai X.M., Dong C. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 2003, 18:863-873.
6. Zang X., Loke P., Kim J., Murphy K., Waitz R., Allison J.P. B7x: a widely expressed B7 family member that inhibits T cell activation. Proc. Natl. Acad. Sci. USA 2003, 100:10388-10392.
7. Sedy J.R., Gavrieli M., Potter K.G., Hurchla M.A., Lindsley R.C., Hildner K., Scheu S., Pfeffer K., Ware C.F., Murphy T.L., et al. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat. Immunol. 2005, 6:90-98.
8. Wang X., Hao J., Metzger D.L., Mui A., Ao Z., Akhoundsadegh N., Langermann S., Liu L., Chen L., Ou D., et al. Early treatment of NOD mice with B7-H4 reduces the incidence of autoimmune diabetes. Diabetes 2011, 60:3246-3255.
9. Delovitch T.L., Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 1997, 7:727-738.
10. Chou F.C., Shieh S.J., Sytwu H.K. Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice. Eur. J. Immunol. 2009, 39:2403-2411.
11. Emamaullee J.A., Davis J., Merani S., Toso C., Elliott J.F., Thiesen A., Shapiro A.M. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 2009, 58:1302-1311.
12. Martin-Orozco N., Chung Y., Chang S.H., Wang Y.H., Dong C. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur. J. Immunol. 2009, 39:216-224.
13. Jain R., Tartar D.M., Gregg R.K., Divekar R.D., Bell J.J., Lee H.H., Yu P., Ellis J.S., Hoeman C.M., Franklin C.L., et al. Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production. J. Exp. Med. 2008, 205:207-218.
14. Ogawa N., List J.F., Habener J.F., Maki T. Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4. Diabetes 2004, 53:1700-1705.
15. Sherry N.A., Kushner J.A., Glandt M., Kitamura T., Brillantes A.M., Herold K.C. Effect of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes. Diabetes 2007, 55:3238-3245.
16. Trudeau J.D., Kelly-Smith C., Verchere C.B., Elliott J.F., Dutz J.P., Finegood D.T., Santamaria P., Tan R. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J. Clin. Invest. 2003, 111:217-223.
17. Anderson B., Park B.J., Verdaguer J., Amrani A., Santamaria P. Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes. Proc. Natl. Acad. Sci. USA 1999, 96:9311-9316.
18. DiLorenzo T.P., Graser R.T., Ono T., Christianson G.J., Chapman H.D., Roopenian D.C., Nathenson S.G., Serreze D.V. Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement. Proc. Natl. Acad. Sci. USA 1998, 95:12538-12543.
19. Vukkadapu S.S., Belli J.M., Ishii K., Jegga A.G., Hutton J.J., Aronow B.J., Katz J.D. Dynamic interaction between T cell-mediated beta-cell damage and beta-cell repair in the run up to autoimmune diabetes of the NOD mouse. Physiol. Genomics 2005, 21:201-211.
20. Bending D., De la Pena H., Veldhoen M., Phillips J.M., Uyttenhove C., Stockinger B., Cooke A. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J. Clin. Invest. 2009, 119:565-572.
21. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005, 6:1133-1141.
22. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
23. Keir M.E., Sharpe A.H. The B7/CD28 costimulatory family in autoimmunity. Immunol. Rev. 2005, 204:128-143.
24. Greenwald R.J., Freeman G.J., Sharpe A.H. The B7 family revisited. Annu. Rev. Immunol. 2005, 23:515-548.
25. Pentcheva-Hoang T., Corse E., Allison J.P. Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections. Immunol. Rev. 2009, 229:67-87.
26. Perrin P.J., Maldonado J.H., Davis T.A., June C.H., Racke M.K. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J. Immunol. 1996, 157:1333-1336.
27. Hurwitz A.A., Sullivan T.J., Sobel R.A., Allison J.P. Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice. Proc. Natl. Acad. Sci. USA 2002, 99:3013-3017.
28. Zhu B., Guleria I., Khosroshahi A., Chitnis T., Imitola J., Azuma M., Yagita H., Sayegh M.H., Khoury S.J. Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 176:3480-3489.
29. Carter L.L., Leach M.W., Azoitei M.L., Cui J., Pelker J.W., Jussif J., Benoit S., Ireland G., Luxenberg D., Askew G.R., et al. PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2007, 182:124-134.
30. Luhder F., Hoglund P., Allison J.P., Benoist C., Mathis D. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J. Exp. Med. 1998, 187:427-432.
31. Ansari M.J., Salama A.D., Chitnis T., Smith R.N., Yagita H., Akiba H., Yamazaki T., Azuma M., Iwai H., Khoury S.J., et al. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 2003, 198:63-69.
32. Keir M.E., Liang S.C., Guleria I., Latchman Y.E., Qipo A., Albacker L.A., Koulmanda M., Freeman G.J., Sayegh M.H., Sharpe A.H. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 2006, 203:883-895.
33. Azuma T., Zhu G., Xu H., Rietz A.C., Drake C.G., Matteson E.L., Chen L. Potential role of decoy B7-H4 in the pathogenesis of rheumatoid arthritis: a mouse model informed by clinical data. PLoS Med. 2009, 6:e1000166.
34. Aoki C.A., Borchers A.T., Ridgway W.M., Keen C.L., Ansari A.A., Gershwin M.E. NOD mice and autoimmunity. Autoimmun. Rev. 2005, 4:373-379.
35. Lehuen A., Diana J., Zaccone P., Cooke A. Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol 2011, 10:501-513.
36. Novak J., Griseri T., Beaudoin L., Lehuen A. Regulation of type 1 diabetes by NKT cells. Int. Rev. Immunol. 2007, 26:49-72.
37. Cederbom L., Hall H., Ivars F. CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 2000, 30:1538-1543.
38. Awasthi A., Carrier Y., Peron J.P., Bettelli E., Kamanaka M., Flavell R.A., Kuchroo V.K., Oukka M., Weiner H.L. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 2007, 8:1380-1389.
39. Mahnke K., Schmitt E., Bonifaz L., Enk A.H., Jonuleit H. Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol. Cell Biol. 2002, 80:477-483.
40. Enk A.H. Dendritic cells in tolerance induction. Immunol. Lett. 2005, 99:8-11.
41. Pot C., Jin H., Awasthi A., Liu S.M., Lai C.Y., Madan R., Sharpe A.H., Karp C.L., Miaw S.C., Ho I.C., et al. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 2009, 183:797-801.
42. Anderson M.S., Bluestone J.A. The NOD mouse: a model of immune dysregulation. Annu. Rev. Immunol. 2005, 23:447-485.
43. Verdaguer J., Schmidt D., Amrani A., Anderson B., Averill N., Santamaria P. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 1997, 186:1663-1676.
44. Hultgren B., Huang X., Dybdal N., Stewart T.A. Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice. Diabetes 1996, 45:812-817.
45. Trembleau S., Penna G., Gregori S., Giarratana N., Adorini L. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma. J. Immunol. 2003, 170:5491-5501.
46. Cruz A., Khader S.A., Torrado E., Fraga A., Pearl J.E., Pedrosa J., Cooper A.M., Castro A.G. Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J. Immunol. 2006, 177:1416-1420.